Amneal Pharmaceuticals Selects Revitas Revenue Management Suite

PHILADELPHIA--(BUSINESS WIRE)--Revitas, Inc., the leading provider of integrated solutions for contract, revenue, and compliance management, today announced that Amneal Pharmaceuticals (Amneal), one of the largest generic drug suppliers in the U.S., has selected the Revitas suite of revenue management solutions to support global growth and meet expanded business requirements. The suite of revenue management applications will be delivered on the strategic and standards-based Revitas® Flex® technology platform.

Help employers find you! Check out all the jobs and post your resume.